Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 15Colorectal Neoplasms 13Neoplasms 12Lung Neoplasms 12Stomach Neoplasms 9Neoplasm Metastasis 6Colonic Neoplasms 6Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Multiple Myeloma 3Melanoma 3Lymphoma, Follicular 3Lymphoma 3Waldenstrom Macroglobulinemia 2Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Thymus Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 1Immunotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Muscle-invasive Bladder Cancer × Drug Therapy × Clear all
NCT07440901 2026-02-27

Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
30 enrolled
Genitourinary

Muscle-invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡